Marsha L. Frazier - Publications

Affiliations: 
Epidemiology & Disease Control The University of Texas School of Public Health 
Area:
Public Health, Molecular Biology, Epidemiology, Oncology

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chen J, Wu X, Huang Y, Chen W, Brand RE, Killary AM, Sen S, Frazier ML. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Oncotarget. PMID 27486767 DOI: 10.18632/Oncotarget.10924  0.386
2016 Zhang T, Tseng C, Zhang Y, Sirin O, Corn PG, Li-Ning-Tapia EM, Troncoso P, Davis J, Pettaway C, Ward J, Frazier ML, Logothetis C, Kolonin MG. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications. 7: 11674. PMID 27241286 DOI: 10.1038/Ncomms11674  0.312
2015 Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, ... ... Frazier ML, et al. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Plos One. 10: e0139049. PMID 26431551 DOI: 10.1371/Journal.Pone.0139049  0.354
2015 Wei C, Peng B, Han Y, Chen WV, Rother J, Tomlinson GE, Richard Boland C, Chaussabel D, Frazier ML, Amos CI. Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers. Familial Cancer. 14: 307. PMID 25820142 DOI: 10.1007/S10689-015-9801-4  0.382
2015 Wei C, Peng B, Han Y, Chen WV, Rother J, Tomlinson GE, Boland CR, Chaussabel D, Chaussabel M, Frazier ML, Amos CI. Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers. Familial Cancer. 14: 297-306. PMID 25716654 DOI: 10.1007/S10689-014-9758-8  0.466
2015 Smith JP, Whitcomb DC, Matters GL, Brand RE, Liao J, Huang YJ, Frazier ML. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. Pancreas. 44: 236-42. PMID 25469546 DOI: 10.1097/Mpa.0000000000000263  0.379
2014 Huang YJ, Frazier ML, Zhang N, Liu Q, Wei C. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. Digestive Diseases and Sciences. 59: 968-75. PMID 24248418 DOI: 10.1007/S10620-013-2938-9  0.384
2014 Huang Y, Zhang N, Frazier M, Wei C. Abstract 2494: A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array Cancer Research. 74: 2494-2494. DOI: 10.1158/1538-7445.Am2014-2494  0.422
2013 Wei C, Chen J, Pande M, Lynch PM, Frazier ML. A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome. Journal of Cancer Research and Clinical Oncology. 139: 1241-50. PMID 23604467 DOI: 10.1007/S00432-013-1437-X  0.561
2013 Burton-Chase AM, Hovick SR, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Clinical Genetics. 83: 215-20. PMID 23414081 DOI: 10.1111/Cge.12091  0.365
2013 Walsh KM, Gorlov IP, Hansen HM, Wu X, Spitz MR, Zhang H, Lu EY, Wenzlaff AS, Sison JD, Wei C, Lloyd SM, Chen W, Frazier ML, Seldin MF, Bierut LJ, et al. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 251-60. PMID 23221128 DOI: 10.1158/1055-9965.Epi-12-1007-T  0.337
2013 Pande M, Thompson PA, Do KA, Sahin AA, Amos CI, Frazier ML, Bondy ML, Brewster AM. Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis. 34: 587-94. PMID 23180655 DOI: 10.1093/Carcin/Bgs369  0.569
2013 Chen J, Pande M, Huang YJ, Wei C, Amos CI, Talseth-Palmer BA, Meldrum CJ, Chen WV, Gorlov IP, Lynch PM, Scott RJ, Frazier ML. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis. 34: 299-306. PMID 23125224 DOI: 10.1093/Carcin/Bgs344  0.643
2013 Smith JP, Frazier ML, Whitcomb DC, Matters G, Brand R, Liao J, McGovern CO, Huang Y, Stello K, Pollock N, LaRusch J. 822 A Single Nucleotide Polymorphism of the Cholecystokinin-B Receptor Predicts Risk & Survival of Pancreatic Cancer Gastroenterology. 144: S-143-S-144. DOI: 10.1016/S0016-5085(13)60517-X  0.381
2013 Pande M, Chen J, Wei C, Huang YJ, Frazier ML. Mutations in Non-MMR genes modifying or mimicking lynch syndrome phenotype Dna Alterations in Lynch Syndrome: Advances in Molecular Diagnosis and Genetic Counselling. 135-169. DOI: 10.1007/978-94-007-6597-9_7  0.517
2012 Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, Spitz MR, Hansen HM, Lu EY, Wei C, Zhang H, Chen W, Lloyd SM, Frazier ML, Bracci PM, et al. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 3: 1428-38. PMID 23232035 DOI: 10.18632/Oncotarget.746  0.422
2012 Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Familial Cancer. 11: 441-7. PMID 22714864 DOI: 10.1007/S10689-012-9534-6  0.64
2012 Liu Q, Chen J, Mai B, Amos C, Killary AM, Sen S, Wei C, Frazier ML. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Molecular Carcinogenesis. 51: 433-8. PMID 21656579 DOI: 10.1002/Mc.20808  0.355
2012 Wei C, Huang Y, Chen J, Pande M, Amos C, Frazier M. Abstract A25: Genetic Variants in 15q25.1 and age onset of Pancreatic Cancer Cancer Prevention Research. 5: A25-A25. DOI: 10.1158/1940-6207.Prev-12-A25  0.624
2011 Wei C, Han Y, Spitz MR, Wu X, Chancoco H, Akiva P, Rechavi G, Brand H, Wun I, Frazier ML, Amos CI. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2603-9. PMID 22028403 DOI: 10.1158/1055-9965.Epi-11-0749  0.392
2011 Bellows CF, Zhang Y, Chen J, Frazier ML, Kolonin MG. Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2461-8. PMID 21930958 DOI: 10.1158/1055-9965.Epi-11-0556  0.361
2011 Chen J, Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas. 40: 872-5. PMID 21697764 DOI: 10.1097/Mpa.0B013E318219Dafe  0.631
2011 Balasenthil S, Chen N, Lott ST, Chen J, Carter J, Grizzle WE, Frazier ML, Sen S, Killary AM. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Cancer Prevention Research (Philadelphia, Pa.). 4: 137-49. PMID 21071578 DOI: 10.1158/1940-6207.Capr-10-0025  0.391
2011 Gorlov IP, Gorlova OY, Frazier ML, Spitz MR, Amos CI. Evolutionary evidence of the effect of rare variants on disease etiology. Clinical Genetics. 79: 199-206. PMID 20831747 DOI: 10.1111/J.1399-0004.2010.01535.X  0.312
2011 Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Attitudes towards colorectal cancer screening in Lynch syndrome families: how do they change from pre-test genetic counseling to 6 and 12-months post-disclosure? Hereditary Cancer in Clinical Practice. 9: P5. DOI: 10.1186/1897-4287-9-S1-P5  0.367
2011 Pande M, Amos C, Lynch P, Lucio L, Chen J, Frazier M. Cancers in DNA mismatch repair mutation carriers: results from a hospital based Lynch syndrome registry Hereditary Cancer in Clinical Practice. 9: P31. DOI: 10.1186/1897-4287-9-S1-P31  0.638
2010 Pande M, Amos CI, Eng C, Frazier ML. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis. Molecular Carcinogenesis. 49: 974-80. PMID 20886582 DOI: 10.1002/Mc.20682  0.589
2010 Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1331-9. PMID 20145170 DOI: 10.1158/1078-0432.Ccr-09-1877  0.591
2010 Coolbaugh-Murphy MI, Xu JP, Ramagli LS, Ramagli BC, Brown BW, Lynch PM, Hamilton SR, Frazier ML, Siciliano MJ. Microsatellite instability in the peripheral blood leukocytes of HNPCC patients. Human Mutation. 31: 317-24. PMID 20052760 DOI: 10.1002/Humu.21190  0.414
2010 Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes & Control : Ccc. 21: 513-21. PMID 20012181 DOI: 10.1007/S10552-009-9482-0  0.375
2010 Chen J, Amos CI, Merriman KW, Wei Q, Sen S, Killary AM, Frazier ML. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas. 39: 1-4. PMID 19910837 DOI: 10.1097/Mpa.0B013E3181Bd51C8  0.371
2010 Pande M, Frazier ML, Lynch PM, Broaddus R, Amos CI. Genome wide association identified colorectal cancer susceptibility loci and colorectal cancer risk in Lynch syndrome Hereditary Cancer in Clinical Practice. 8: P16. DOI: 10.1186/1897-4287-8-S1-P16  0.631
2010 Wei C, Frazier M, Wun I, Amos C. Abstract A125: Genetic variation in nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A125  0.409
2010 Pande M, Frazier ML, Lynch PM, Broaddus R, Reuther J, Jiang W, Amos CI. Abstract A124: Genome‐wide association identified susceptibility loci as modifiers of colorectal cancer risk in Lynch syndrome Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A124  0.662
2010 Wang J, Katayama H, Leblanc AB, Frazier ML, Killary AM, Sen S. Abstract LB-350: MicroRNA-301a, elevated in pancreatic cancer, targets tumor suppressor CDKN1A/p21 blocking cellular senescence and promoting invasion of pancreatic epithelial cells Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-350  0.327
2010 Wei C, Zhang N, Liu Q, Amos C, Frazier M. Abstract 1127: Dysregulation of tumor suppress gene LKB1 in pancreatic cancer Cancer Research. 70: 1127-1127. DOI: 10.1158/1538-7445.Am10-1127  0.466
2009 Chen J, Etzel CJ, Amos CI, Zhang Q, Viscofsky N, Lindor NM, Lynch PM, Frazier ML. Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome. Cancer Causes & Control : Ccc. 20: 1769-77. PMID 19690970 DOI: 10.1007/S10552-009-9416-X  0.418
2009 Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, ... ... Frazier ML, et al. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. Plos Medicine. 6: e1000068. PMID 19536326 DOI: 10.1371/Journal.Pmed.1000068  0.333
2009 Wei C, Amos CI, Zhang N, Zhu J, Wang X, Frazier ML. Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model. Cancer Letters. 277: 149-54. PMID 19147279 DOI: 10.1016/J.Canlet.2008.11.036  0.315
2009 Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Annals of Surgical Oncology. 16: 431-9. PMID 19020940 DOI: 10.1245/S10434-008-0220-8  0.371
2008 Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2393-401. PMID 18768509 DOI: 10.1158/1055-9965.Epi-08-0326  0.66
2008 Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Letters. 272: 32-9. PMID 18694622 DOI: 10.1016/J.Canlet.2008.06.022  0.383
2008 Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, ... ... Frazier ML, et al. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 826-36. PMID 18488000 DOI: 10.1038/Modpathol.2008.46  0.36
2007 Pande M, Chen J, Amos CI, Lynch PM, Broaddus R, Frazier ML. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1753-9. PMID 17855693 DOI: 10.1158/1055-9965.Epi-07-0384  0.643
2007 Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3100-4. PMID 17505013 DOI: 10.1158/1078-0432.Ccr-06-2319  0.402
2007 Chen J, Sen S, Amos CI, Wei C, Jones JS, Lynch P, Frazier ML. Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Molecular Carcinogenesis. 46: 249-56. PMID 17219423 DOI: 10.1002/Mc.20283  0.452
2006 Gu J, Berman D, Lu C, Wistuba II, Roth JA, Frazier M, Spitz MR, Wu X. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7329-38. PMID 17189404 DOI: 10.1158/1078-0432.Ccr-06-0894  0.368
2006 Jones JS, Amos CI, Pande M, Gu X, Chen J, Campos IM, Wei Q, Rodriguez-Bigas M, Lynch PM, Frazier ML. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 886-91. PMID 16702365 DOI: 10.1158/1055-9965.Epi-05-0644  0.662
2006 Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1720-8. PMID 16520463 DOI: 10.1200/Jco.2005.04.4206  0.417
2006 Zecevic M, Amos CI, Gu X, Campos IM, Jones JS, Lynch PM, Rodriguez-Bigas MA, Frazier ML. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. Journal of the National Cancer Institute. 98: 139-43. PMID 16418517 DOI: 10.1093/Jnci/Djj016  0.456
2006 Chen LL, Prieto VG, Sabripour M, Wu EF, Raymond AK, Sang H, Frazier ML. Loss of heterozygosity with acquisition of homozygous KIT-activating mutation promotes gastrointestinal stromal tumor progression Journal of Clinical Oncology. 24: 9530-9530. DOI: 10.1200/Jco.2006.24.18_Suppl.9530  0.364
2006 Chen J, Zhu J, Pande M, Amos J, Frazier ML, Wei C. Modifiers of expression in mutations of mismatch repair gene carriers in hereditary nonpolyposis colorectal cancer Current Colorectal Cancer Reports. 2: 179-184. DOI: 10.1007/S11888-006-0020-0  0.65
2005 Wei C, Amos CI, Stephens LC, Campos I, Deng JM, Behringer RR, Rashid A, Frazier ML. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Research. 65: 11297-303. PMID 16357136 DOI: 10.1158/0008-5472.Can-05-0716  0.301
2005 Jones JS, Gu X, Lynch PM, Rodriguez-Bigas M, Amos CI, Frazier ML. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes & Control : Ccc. 16: 749-53. PMID 16049814 DOI: 10.1007/S10552-005-1540-7  0.489
2005 Chen LL, Sabripour M, Wu EF, Prieto VG, Fuller GN, Frazier ML. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene. 24: 4271-80. PMID 15824741 DOI: 10.1038/Sj.Onc.1208587  0.307
2005 Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1902-10. PMID 15774782 DOI: 10.1200/Jco.2005.07.102  0.397
2005 Wei C, Rashid A, Amos C, Gannon M, Frazier ML. LKB1 GENE TISSUE SPECIFIC KNOCKOUT MOUSE MODEL FOR PANCREATIC CANCER Pancreas. 31: 478. DOI: 10.1097/01.Mpa.0000193795.44003.Bb  0.386
2004 Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutation Research. 554: 175-83. PMID 15450416 DOI: 10.1016/J.Mrfmmm.2004.04.014  0.379
2004 Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5845-9. PMID 15355915 DOI: 10.1158/1078-0432.Ccr-03-0590  0.511
2004 Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, ... ... Frazier ML, et al. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Research. 64: 5913-9. PMID 15342366 DOI: 10.1158/0008-5472.Can-04-0085  0.314
2004 Coolbaugh-Murphy M, Maleki A, Ramagli L, Frazier M, Lichtiger B, Monckton DG, Siciliano MJ, Brown BW. Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR. Genomics. 84: 419-30. PMID 15234004 DOI: 10.1016/J.Ygeno.2004.03.007  0.331
2004 Amos CI, Keitheri-Cheteri MB, Sabripour M, Wei C, McGarrity TJ, Seldin MF, Nations L, Lynch PM, Fidder HH, Friedman E, Frazier ML. Genotype-phenotype correlations in Peutz-Jeghers syndrome. Journal of Medical Genetics. 41: 327-33. PMID 15121768 DOI: 10.1136/Jmg.2003.010900  0.327
2004 Jones JS, Gu X, Campos IM, Lynch PM, Amos CI, Frazier ML. GSTM1 polymorphism does not affect hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 676-8. PMID 15066938  0.336
2003 Wei C, Amos CI, Rashid A, Sabripour M, Nations L, McGarrity TJ, Frazier ML. Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 51: 1665-72. PMID 14623934 DOI: 10.1177/002215540305101210  0.374
2003 Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. American Journal of Human Genetics. 73: 1157-61. PMID 14526391 DOI: 10.1086/378819  0.328
2003 McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK. Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome. The American Journal of Gastroenterology. 98: 671-8. PMID 12650805 DOI: 10.1016/S0002-9270(02)06050-1  0.32
2001 Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR, Wei Q. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 22: 1195-9. PMID 11470749 DOI: 10.1093/Carcin/22.8.1195  0.373
2001 Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. Journal of the National Cancer Institute. 93: 1106-8. PMID 11459873 DOI: 10.1093/Jnci/93.14.1106  0.471
2001 Frazier ML, O'Donnell FT, Kong S, Gu X, Campos I, Luthra R, Lynch PM, Amos CI. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Research. 61: 1269-71. PMID 11245417  0.375
2000 Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC, Yu Y. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. International Journal of Cancer. Journal International Du Cancer. 86: 690-4. PMID 10797292 DOI: 10.1002/(Sici)1097-0215(20000601)86:5<690::Aid-Ijc14>3.0.Co;2-K  0.374
2000 Amos CI, Frazier ML, Wang W. DNA pooling in mutation detection with reference to sequence analysis. American Journal of Human Genetics. 66: 1689-92. PMID 10733464 DOI: 10.1086/302894  0.301
2000 Wei Q, Frazier ML, Levin B. DNA repair: a double-edged sword. Journal of the National Cancer Institute. 92: 440-1. PMID 10716953 DOI: 10.1093/Jnci/92.6.440  0.384
2000 Fernández-Salas E, Peracaula R, Frazier ML, de Llorens R. Ribonucleases expressed by human pancreatic adenocarcinoma cell lines. European Journal of Biochemistry / Febs. 267: 1484-94. PMID 10691987 DOI: 10.1046/J.1432-1327.2000.01148.X  0.35
2000 Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Research. 60: 249-52. PMID 10667569  0.33
1999 Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, Frazier ML. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology. 117: 350-8. PMID 10419916 DOI: 10.1053/Gast.1999.0029900350  0.408
1999 Frazier ML. Gene expression in pancreatic adenocarcinoma. Annals of the New York Academy of Sciences. 880: 1-4. PMID 10415845 DOI: 10.1111/J.1749-6632.1999.Tb09504.X  0.313
1999 Frazier ML, Sinicrope FA, Amos CI, Cleary KR, Lynch PM, Levin B, Luthra R. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer. Oncology Reports. 6: 497-505. PMID 10203581 DOI: 10.3892/Or.6.3.497  0.387
1999 Lin X, Choi JH, Lynch P, Xi L, Wu E, Frazier ML. Reduction in hMSH2 mRNA levels by premature translation termination: implications for mutation screening in hereditary nonpolyposis colorectal cancer. Digestive Diseases and Sciences. 44: 553-9. PMID 10080150 DOI: 10.1023/A:1026609524482  0.4
1998 Frazier ML, Inamdar N, Alvula S, Wu E, Kim YH. Few point mutations in elongation factor-1gamma gene in gastrointestinal carcinoma. Molecular Carcinogenesis. 22: 9-15. PMID 9609096 DOI: 10.1002/(Sici)1098-2744(199805)22:1<9::Aid-Mc2>3.0.Co;2-J  0.46
1996 Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. Annals of Surgical Oncology. 3: 241-6. PMID 8726178 DOI: 10.1007/Bf02306278  0.349
1996 Jeon HM, Lynch PM, Howard L, Ajani J, Levin B, Frazier ML. Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer. Human Mutation. 7: 327-33. PMID 8723682 DOI: 10.1002/(Sici)1098-1004(1996)7:4<327::Aid-Humu6>3.0.Co;2-5  0.435
1995 Lynch P, Jeon H, Howard L, Ajani J, Levin B, Frazier M. Common hMSH2 mutation in unrelated families with a variable family history of colorectal cancer Gastroenterology. 108: A499. DOI: 10.1016/0016-5085(95)26312-8  0.367
1994 Longnecker DS, Pour PM, Scarpelli DG, Caldas C, Redston MS, Hahn SA, Seymour AB, Hruban RH, Yeo CJ, Kern SE, Ruggeri BA, Klein-Szanto AJP, Huang LY, Lang D, Andr’en-Sandberg Å, ... ... Frazier ML, et al. Investigational strategies for detection and intervention in early-stage pancreatic cancer International Journal of Pancreatology. 16: 183-310. PMID 7868945 DOI: 10.1007/Bf02944330  0.327
1993 Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML. Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas. Molecular Carcinogenesis. 7: 18-20. PMID 8382068 DOI: 10.1002/Mc.2940070104  0.351
1991 Chi K, Jessup JM, Frazier ML. Predominant expression of mRNA coding for nonspecific cross-reacting antigen in colorectal carcinomas Tumor Biology. 12: 298-308. PMID 1962152 DOI: 10.1159/000217718  0.307
Show low-probability matches.